Patent Baristas

I know I preach that over-consumerism is a bad thing (see: simplify | the benefits of minimalism) but we’re back again this year with a list of the best gifts for patent geeks and entrepreneurs.  Here are some ideas to stimulate discussion.  So, sit back over a cup o’ joe and take some time to […]

The University of Baltimore School of Law’s Intellectual Property Law Journal seeks articles for its Spring 2011 symposium issue.  The symposium’s theme is: “The Incentive to Invent: Intellectual Property Protection and the U.S. Biotechnology and Pharmaceutical Industries.” The symposium seeks to explore issues and trends related to the role which intellectual property plays in the […]

Teva Pharmaceuticals has launched a new online game promotion generic substitution among consumers. The link is below – as you can see, it allows players to replace popular brand-name drugs with their generic equivalents, and it shows how much one would save if they made the switch. According to Teva PR, they’ve had 17,000 views […]

The United States Patent and Trademark Office (USPTO) is implementing a pilot program (Extended Missing Parts Pilot Program) in which an applicant can request a twelve-month time period to pay certain fees and to reply to a Notice to File Missing Parts of Nonprovisional Application. Under the Extended Missing Parts Pilot Program, applicant must file […]

Deservedly or not, Patent Baristas has been featured on the Guide to Online School’s list of the Top 50 Patent blogs.  For the list, Online Schools hand-picked a list of their favorite patent blogs and outlined the unique reasons why they think they’re great. The blogs were selected because they demonstrate expertise and thorough knowledge […]

“In every crisis, there is opportunity” ~Chinese Proverb With a GDP of more than $8,000 billion, China is poised to become the world’s third-largest pharmaceutical market next year – up from number eight in 2006.  The $24.5 billion pharmaceutical market is expected to swell to $68 billion to $78 billion by 2013, leaving it behind […]

The APO has issued a decision which has created uncertainty regarding the patentability of business methods. Until recently, our advice to clients was that business methods were patentable in AU, provided that the claims were limited to execution of the business method in a computer environment. The APO has now issued the Iowa Lottery decision […]

In a recent paper by Yali Friedman of the BiotechBlog, Yali looks at the growth of research capabilities in emerging economies such as India and China. With a substantial increase in the outsourcing of some of the more routine activities involved in pharmaceutical research and development (R&D), such as compound synthesis and preclinical toxicity tests, […]